- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03815968
Low Sodium Diet in Oligohydramnios Assigned for Conservative Management
The Influence of Low Sodium Diet on an Amniotic Fluid Index in a Patient That Diagnosed With Oligohydramnios and Assigned for Conservative Management - a Randomized Controlled Trial
Study Overview
Detailed Description
Few studies have addressed the changes in maternal diet as affecting the composition and amount of amniotic fluid.
Some articles have shown an increase in amniotic fluid volume as a result of maternal hydration during pregnancy through intravenous fluid infusions and oral fluid intake, the increase was evident in women with amniotic fluid and women with normal amniotic fluid volume. In a mechanism similar to that of liquid hydration, a low-salt diet may lead to an increase in the volume of amniotic fluid.
The investigators would like to examine whether a low-salt diet in women with amniotic fluid is able to significantly increase the amount of amniotic fluid compared with a regular diet.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michal Levy, MD
- Phone Number: 0528591994
- Email: levmichal@gmail.com
Study Contact Backup
- Name: Eran Weiner, MD
- Email: eranweiner.md@gmail.com
Study Locations
-
-
-
H̱olon, Israel, 6404519
- Departments of Obstetrics & Gynecology, affiliated with Sackler Faculty of Medicine, Tel Aviv University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women between 24-37 weeks of gestation, single fetus, who were diagnosed with an amniotic fluid index at the 5th percentile or below, according to the current gestational age
- No medical indication for immediate delivery
Exclusion Criteria:
- Refusal to participate in the study
- A medical recommendation for delivery within two weeks of diagnosis
- Fetal malformation or proof of fetal infection that known to cause oligohydramnios (eg CMV).
- Premature rupture of membrane
- Multiple pregnancy
- Medical contraindication to the low-salt diet
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low sodium diet
women diagnosed with oligohydramnios designated for conservative management applying a low-salt diet.
|
included in the diet mostly low sodium food.
avoid tinned or smoked, food.
avoid adding salt to the food.
Other Names:
|
No Intervention: regular diet
women diagnosed with oligohydramnios designated for conservative management applying a regular diet.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
amniotic fluid volume, assessed by ultrasound
Time Frame: two weeks
|
amniotic fluid volume after two weeks
|
two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
gestational age at birth
Time Frame: up to 18 weeks (until delivery)
|
up to 18 weeks (until delivery)
|
|
induction of labor
Time Frame: up to 18 weeks (until delivery)
|
The percentage of pregnant women who underwent birth induction
|
up to 18 weeks (until delivery)
|
labor type
Time Frame: up to 18 weeks (until delivery)
|
Cesarean section, vaginal birth or vaginal birth
|
up to 18 weeks (until delivery)
|
Pregnancy and childbirth complications
Time Frame: up to 18 weeks (until delivery)
|
obstetrics complications and neonatal complications
|
up to 18 weeks (until delivery)
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Rabie N, Magann E, Steelman S, Ounpraseuth S. Oligohydramnios in complicated and uncomplicated pregnancy: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017 Apr;49(4):442-449. doi: 10.1002/uog.15929.
- Rainford M, Adair R, Scialli AR, Ghidini A, Spong CY. Amniotic fluid index in the uncomplicated term pregnancy. Prediction of outcome. J Reprod Med. 2001 Jun;46(6):589-92.
- Koski KG, Fergusson MA. Amniotic fluid composition responds to changes in maternal dietary carbohydrate and is related to metabolic status in term fetal rats. J Nutr. 1992 Feb;122(2):385-92. doi: 10.1093/jn/122.2.385.
- Gurekian CN, Koski KG. Amniotic fluid amino acid concentrations are modified by maternal dietary glucose, gestational age, and fetal growth in rats. J Nutr. 2005 Sep;135(9):2219-24. doi: 10.1093/jn/135.9.2219.
- Flack NJ, Sepulveda W, Bower S, Fisk NM. Acute maternal hydration in third-trimester oligohydramnios: effects on amniotic fluid volume, uteroplacental perfusion, and fetal blood flow and urine output. Am J Obstet Gynecol. 1995 Oct;173(4):1186-91. doi: 10.1016/0002-9378(95)91350-5.
- Doi S, Osada H, Seki K, Sekiya S. Effect of maternal hydration on oligohydramnios: a comparison of three volume expansion methods. Obstet Gynecol. 1998 Oct;92(4 Pt 1):525-9. doi: 10.1016/s0029-7844(98)00242-7.
- Umber A, Chohan MA. Intravenous maternal hydration in third trimester oligohydramnios: effect on amniotic fluid volume. J Coll Physicians Surg Pak. 2007 Jun;17(6):336-9.
- Rakova N, Muller DN, Staff AC, Luft FC, Dechend R. Novel ideas about salt, blood pressure, and pregnancy. J Reprod Immunol. 2014 Mar;101-102:135-139. doi: 10.1016/j.jri.2013.04.001. Epub 2013 May 30.
- Kirksey A, Pike RL, Callahan JA. Some effects of high and low sodium intakes during pregnancy in the rat. II. Electrolyte concentrations of maternal plasma, muscle, bone and brain and of placenta, amniotic fluid, fetal plasma and total fetus in normal pregnancy. J Nutr. 1962 May;77(1):43-51. doi: 10.1093/jn/77.1.43. No abstract available.
- Moore TR, Cayle JE. The amniotic fluid index in normal human pregnancy. Am J Obstet Gynecol. 1990 May;162(5):1168-73. doi: 10.1016/0002-9378(90)90009-v.
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0008-19-WOMC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oligohydramnios
-
Zagazig UniversityCompletedOligohydramnios, DeliveredSaudi Arabia
-
Benha UniversityCompletedIsolated (Idiopathic) Oligohydramnios
-
Szeged UniversityUnknownSevere OligohydramniosHungary
-
Antalya Training and Research HospitalRecruiting
-
Sisli Hamidiye Etfal Training and Research HospitalCompleted
-
Woman's Health University Hospital, EgyptTerminated
-
PediatrixBanner HealthTerminated
-
Kayseri Education and Research HospitalUnknown
-
Aswan University HospitalRecruiting
Clinical Trials on low sodium diet
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Ospedali Riuniti di FoggiaCompleted
-
University of DelawareCompleted
-
Regional Hospital HolstebroCompletedHealthy HumansDenmark
-
Medical College of WisconsinRecruiting
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Apoio...CompletedHeart Failure; With Decompensation | Heart Failure,CongestiveBrazil
-
Maastricht University Medical CenterCompletedHypertension | Metabolic Syndrome | Insulin Resistance | Abdominal Obesity | Sodium-sensitivityNetherlands
-
DongGuk UniversityBoryung Pharmaceutical Co., LtdCompletedHypertensionKorea, Republic of
-
University of VirginiaNational Heart, Lung, and Blood Institute (NHLBI)Unknown
-
Tulane University School of Public Health and Tropical...CompletedChronic Kidney Disease | AlbuminuriaUnited States